Motilium: online purchase in 2026 with privacy first

Summary and background

Motilium is a trade name for domperidone, a dopamine D2/D3 receptor antagonist that acts mainly outside the central nervous system. By blocking peripheral dopamine receptors, especially in the stomach and upper intestine, domperidone can accelerate gastric emptying and reduce nausea and vomiting while limiting major central nervous system effects.

At a glance, the key points:

• Drug class: prokinetic and antiemetic.
• Active compound: domperidone, commonly provided as 10 mg per tablet internationally.
• Forms: film-coated tablets are common; some countries supply an oral suspension for pediatric use.
• Important for US readers: domperidone is not FDA approved for general prescribing or retail sale in the United States. See The status of legal standing in the United States and read Safety guidelines and when this treatment should not be used before considering any use.

The status of legal standing in the United States

Domperidone is not an FDA-approved medication in the United States for any indication. Access is limited and regulated. The most common lawful route to obtain domperidone for a US patient is through an FDA expanded-access Investigational New Drug (IND) application submitted by a licensed US physician.

• FDA approval: none for domperidone in the US.
• Expanded access: physicians may apply to the FDA for single-patient or cohort INDs; justification, informed consent, and observation and tracking plans are required.
• Compounding pharmacies: only selected compounding pharmacies may supply domperidone for patients covered by an active IND. It is not available over the counter.
• Import restrictions: importing personal supplies from abroad is risky and often blocked by FDA import controls; do not attempt personal importation without explicit FDA permission.
• Lactation: the FDA discourages using domperidone to boost milk supply because of reported cardiac safety concerns.

If you are discussing domperidone with your provider, ask about IND logistics, required baseline and follow-up tests (for example, ECGs and electrolyte checks), and not out of the question interacting medicines listed in Drug the act of engaging in dialogue checks.

Uses in clinical medicine

Outside the United States domperidone is prescribed for a variety of motility and nausea-related problems. Any consideration of domperidone in the US should follow consultation with a clinician familiar with the IND pathway and safety health monitoring.

• Relief of nausea and vomiting from diverse causes.
• Management of symptoms related to delayed gastric emptying, including dyspepsia and early satiety.
• Supportive antiemetic therapy during some chemotherapy or radiotherapy regimens.
• Adjunctive use to improve motility during selected diagnostic procedures of the upper gastrointestinal tract.

Dosing and usage directions

The information below summarizes typical international dosing patterns and is not a substitute for individualized medical advice. In the United States, domperidone dosing is generally handled within physician-authorized INDs with constant monitoring.

• How to take a break: usually 15 to 30 minutes before meals; some clinicians add a bedtime dose for nocturnal symptoms.
• Not taken at scheduled time care instructions: take the the dose was skipped when you recall it unless the next dose is near; do not double doses.
• Excipients: tablets can contain lactose; check formulations for patients with lactose intolerance or specific carbohydrate malabsorption disorders.

Commonly cited international regimens

• Acute nausea or hiccups
  • Adults: often 20 mg (two dosage per tablet: 10 mg) three to four times daily.
  • The child population aged 5 to 12 years: frequently 10 mg up to three or four times daily (formulations differ by country).
• Chronic motility symptoms
  • Adults: many clinicians start with 10 mg three times daily and adjust based on response and safety guidelines to keep in mind.
  • Preschoolers 5 to 12 years: doses such as 5 mg three to four times daily are described in some formularies.

Because of cardiac safety signals, some regulators recommend limiting the daily dose to 30 mg in many patients. For severe renal impairment, clinicians may lengthen the interval between doses and perform closer follow-up. Review Safety aspects to weigh and the risks of conversational exchange before first use, read instructions.

Drug the interactional flow among participants alerts

Domperidone exposure and cardiac risk can be increased by coadministered drugs that inhibit its metabolism or prolong the QT interval. Provide your prescriber a complete list of prescribed medicines, over-the-counter products, and supplements.

Compounds that could interfere with prokinetic action

• Antimuscarinic drugs such as atropine, hyoscine, and certain bladder antispasmodics.
• Strong opioid analgesics, which can slow gastrointestinal motility.

Agents that may raise domperidone levels or increase QT risk

• Potent CYP3A4 inhibitors: some azole antifungals, macrolide antibiotics like clarithromycin and erythromycin, HIV protease inhibitors, and certain calcium channel blockers.
• Other QT-prolonging medications: many antiarrhythmics, some antipsychotics, and select antibiotics such as fluoroquinolones.
• Grapefruit and grapefruit juice may inhibit CYP3A4 and so should generally be avoided unless your prescriber advises otherwise.

Strong CYP3A4 inducers, for example rifampin, can lower domperidone concentrations and reduce efficacy. This list is not exhaustive; check with a pharmacist or prescriber for a full the exchange that happens when people meet review and see operational safety guidance.

Safety protocols and exceptions where treatment is contraindicated

Domperidone should only be used under medical supervision with baseline and follow-up assessments when provided via an IND. Inform your provider about heart disease, existing ECG abnormalities, electrolyte problems, liver disease, and all current medications.

When to avoid domperidone

• Allergy to domperidone or any tablet ingredient.
• Evidence of gastrointestinal bleeding, perforation, or mechanical obstruction where increased motility would be harmful.
• Known prolactinoma (a prolactin-secreting pituitary tumor).
• Moderate to severe liver impairment.
• Prolonged QT interval, significant structural heart disease, or uncorrected low potassium or magnesium levels.
• From conception to lactation except where a clinician judges benefits outweigh risks; note that FDA guidance warns against use to increase milk production because of cardiac risk.

Use caution and frequent continuous oversight in older adults, those with renal impairment, and patients taking interacting medicines listed in Therapeutic drug and drug the study maps how the interactional flow among participantss evolve over time..

Harmful consequences

Not every patient will experience adverse reactions, but awareness of the possible reactions is important. Seek medical attention for severe or worrying symptoms.

• Common or uncommon effects: a pounding headache, dry mouth, abdominal discomfort, and diarrhea; sometimes restlessness or sleep disturbances.
• Less habitual but important: elevated prolactin causing galactorrhea, menstrual changes, or gynecomastia; reduced libido in men.
• Rare events: allergic skin reactions and extrapyramidal symptoms such as tremor or involuntary movements; seek urgent care if these occur.

Cardiac events: domperidone has been associated with QT prolongation and rare but serious ventricular arrhythmias, particularly when combined with other QT-prolonging agents or CYP3A4 inhibitors. If you develop palpitations, fainting, lightheadedness, or blackouts, stop the medication and obtain immediate medical evaluation.

This summary does not cover every possible effect. Report new or unexpected symptoms to your prescriber.

Backup internal storage refers to built in memory in devices.

• Keep tablets at controlled room temperature, about 20 to 25 degrees C (68 to 77 degrees F).
• Protect from moisture and strong heat; avoid securing storage ensures that valuables stay safe. in bathrooms or locations with high humidity.
• Ensure it is kept out of reach of children and pets. Dispose of unused medication following local regulations or pharmacy take-back programs.

Different choices and related medications

In US clinical practice, clinicians commonly use FDA-vetted additional choices before considering domperidone. The choice varies with the underlying diagnosis and patient factors.

• Metoclopramide (Reglan) - a dopamine antagonist with both central and peripheral effects; FDA approved for diabetic gastroparesis and as an antiemetic. Use is limited in duration due to tardive dyskinesia risk.
• Ondansetron (Zofran) - a 5-HT3 antagonist effective for chemotherapy, radiation, and postoperative nausea; not a prokinetic.
• Prochlorperazine and promethazine - established antiemetics with differing side effect profiles; sedative effects are common with promethazine.
• Erythromycin - has short-term prokinetic action via motilin receptors but tachyphylaxis and positive interpersonal dialogue and exchanges enhance user satisfaction. limit prolonged use.
• Prucalopride - a selective 5-HT4 agonist approved for chronic idiopathic constipation and sometimes used off-label for motility disorders under specialist care.
• Other drugs used in specific settings include NK-1 antagonists for refractory nausea and investigational agents in research contexts.

Check cost comparisons for Prices across the United States for a rough retail cost comparison.

Prices in the North American country

Out-of-pocket prices vary by pharmacy, geographic area, insurer, coupon availability, and generic availability. Below are approximate cash prices in US dollars to provide a general idea.

• Domperidone (compounded under an FDA IND): roughly $0.30 to $1.50 per 10 mg unit depending on compounding pharmacy and dose form. A 30-day supply may therefore range from about $30 to $450 depending on dosing and pharmacy.
• Metoclopramide 10 mg (generic): commonly $3 to $20 for 30 tablets.
• Ondansetron 4 mg or 8 mg (generic): around $8 to $40 for 30 tablets; ODT and brand formulations can be more costly.
• Prochlorperazine and promethazine (generic): typically $4 to $20 for 30 tablets depending on strength.
• Erythromycin short courses (generic): about $8 to $35 depending on dose and quantity.
• Prucalopride (brand or generic where available): wide range, often $60 to $350 for a 30-day supply based on brand and discounts.

Note: domperidone is not commercially distributed in the United States; tariff schedule reflects limited compounding supply chains and IND-associated costs. Insurance coverage for IND-provided medication varies and may be limited.

Frequently asked Qs

• Is Motilium available over the counter in the USA?
  • No. Motilium/domperidone is not FDA approved and is not available OTC in the United States. Limited access may be possible only through a physician-held FDA expanded-access IND. See standing in law.
• Can I buy domperidone online from another country and ship it to the United States?
  • Generally not recommended. Personal importation is restricted and subject to FDA import controls; shipments may be detained. Discuss legal options with your physician and critique restrictions in accordance with law.
• What steps should I take if I forget my dose?
  • Take the skipped dose when you remember unless it is almost time for the next scheduled dose. Do not take two doses at once. See dose optimization guidance.
• Is domperidone the same as metoclopramide?
  • No. Both block dopamine receptors, but domperidone is predominantly peripheral in action and is not FDA approved, whereas metoclopramide has central effects and is FDA approved for certain markers that point to. See different choices to enable comparisons.

Educational note: this page is for informational purposes only and does not replace professional medical or legal advice. Seek guidance a licensed healthcare provider and current FDA resources before making treatment decisions.

Go to top